Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ZEPU-AI3 Lower Limb Feedback Robot Training Study

NCT: NCT07705906 · NOT_YET_RECRUITING

NCT IDNCT07705906
StatusNOT_YET_RECRUITING
Start Date2026-07-15
Completion2026-11-15
SponsorBangladesh Medical University (OTHER)
First posted
Last updated

Brief Summary

Lower limb motor dysfunction resulting from stroke, spinal cord injury, or other neurological disorders substantially limits mobility, independence, and quality of life. Robotic rehabilitation has emerged as a promising approach to provide intensive, repetitive, task-oriented training. The ZEPU-AI3 Lower Limb Feedback Training and Evaluation Robot is designed to deliver interactive lower limb training while providing real-time performance feedback. This pilot randomized controlled trial aims to evaluate the safety, efficacy, and feasibility of ZEPU-AI3-assisted rehabilitation combined with conventional rehabilitation compared with conventional rehabilitation alone in patients with lower limb motor dysfunction. The primary outcomes include safety, feasibility, and changes in lower limb motor function, gait performance, and functional mobility. The findings will provide preliminary evidence to support future large-scale clinical trials and the implementation of robotic rehabilitation in clinical practice.

Frequently Asked Questions

What is ZEPU-AI3 Lower Limb Feedback Robot Training Study?

ZEPU-AI3 Lower Limb Feedback Robot Training Study is a clinical trial registered under NCT07705906. Current status: NOT_YET_RECRUITING.

What is the status of NCT07705906?

The current status of NCT07705906 (ZEPU-AI3 Lower Limb Feedback Robot Training Study) is: NOT_YET_RECRUITING.

When did ZEPU-AI3 Lower Limb Feedback Robot Training Study start?

ZEPU-AI3 Lower Limb Feedback Robot Training Study started on 2026-07-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.